Monday, June 10, 2024

10:35 AM - 10:55 AM

214

---

Overview

Dr. Chad Bousman

---

Details

R2: By the end of this session, participants will be able to: •Explain the rationale and evidence for using pharmacogenetic-guided prescribing •Identify care situations where pharmacogenetic testing could be useful in child and youth mental health •Describe an ongoing pharmacogenetic testing implementation project in Western Canada

---

Speaker